Literature DB >> 15634313

Treatment and management of challenging behaviours in congregate and noncongregate community-based supported accommodation.

J Robertson1, E Emerson, L Pinkney, E Caesar, D Felce, A Meek, D Carr, K Lowe, M Knapp, A Hallam.   

Abstract

OBJECTIVES: To compare the nature and prevalence of use of procedures employed to treat and manage challenging behaviours across two approaches to providing community-based supported accommodation for people with intellectual disabilities (ID) and severe challenging behaviour: noncongregate settings where the minority of residents have challenging behaviour, and congregate settings where the majority of residents have challenging behaviour.
SETTING: Community-based supported accommodation for people with ID and challenging behaviour.
DESIGN: Longitudinal matched groups design. MAIN OUTCOME MEASURES: The nature and prevalence of use of procedures employed to treat and manage challenging behaviours. Observed and reported severity of challenging behaviours.
RESULTS: Both types of settings were associated with low prevalence of use of behavioural technologies for the reduction of challenging behaviour (less than 15% of participants). In contrast, high proportions of participant received antipsychotic medication in both noncongregate (56%) and congregate (80%) settings. Congregate settings were associated with the increased use of physical restraint as a reactive management strategy, with over half of participants being in receipt of physical restraint by two or more members of staff. DISCUSSION: Changes in reported and observed challenging behaviour over a 10-month period were slight. The use of evidence-based behavioural technologies for the reduction of challenging behaviour may have led to better outcomes.

Entities:  

Mesh:

Year:  2005        PMID: 15634313     DOI: 10.1111/j.1365-2788.2005.00663.x

Source DB:  PubMed          Journal:  J Intellect Disabil Res        ISSN: 0964-2633


  8 in total

1.  The association between repetitive, self-injurious and aggressive behavior in children with severe intellectual disability.

Authors:  Chris Oliver; Jane Petty; Loraine Ruddick; Monique Bacarese-Hamilton
Journal:  J Autism Dev Disord       Date:  2012-06

Review 2.  Pharmacists' medicines-related interventions for people with intellectual disabilities: a narrative review.

Authors:  Máire O'Dwyer; Arijana Meštrović; Martin Henman
Journal:  Int J Clin Pharm       Date:  2015-04-24

Review 3.  Diagnosis and treatment of aggression in individuals with developmental disabilities.

Authors:  Diana J Antonacci; Crystal Manuel; Ervin Davis
Journal:  Psychiatr Q       Date:  2008-08-23

4.  Persistence of self-injurious behaviour in autism spectrum disorder over 3 years: a prospective cohort study of risk markers.

Authors:  Caroline Richards; Jo Moss; Lisa Nelson; Chris Oliver
Journal:  J Neurodev Disord       Date:  2016-05-05       Impact factor: 4.025

Review 5.  Non-pharmacological interventions for challenging behaviours of adults with intellectual disabilities: A meta-analysis.

Authors:  E Bruinsma; B J van den Hoofdakker; A P Groenman; P J Hoekstra; G M de Kuijper; M Klaver; A A de Bildt
Journal:  J Intellect Disabil Res       Date:  2020-06-17

6.  Approaches used to prevent and reduce the use of restrictive practices on adults with learning disabilities: Protocol for a realist review.

Authors:  Alina Haines-Delmont; Anthony Tsang; Kirstine Szifris; Elaine Craig; Melanie Chapman; John Baker; Peter Baker; James Ridley; Michaela Thomson; Gary Bourlet; Beth Morrison; Joy Duxbury
Journal:  PLoS One       Date:  2022-09-28       Impact factor: 3.752

7.  Treating Individuals With Intellectual Disabilities and Challenging Behaviors With Adapted Dialectical Behavior Therapy.

Authors:  Julie F Brown; Milton Z Brown; Paige Dibiasio
Journal:  J Ment Health Res Intellect Disabil       Date:  2013-10

8.  Self-Injurious Behavior in People with Intellectual Disabilities and Co-Occurring Psychopathology using the Self-Harm Scale: A Pilot Study.

Authors:  Kim J H M van den Bogaard; Henk L I Nijman; Tom Palmstierna; Petri J C M Embregts
Journal:  J Dev Phys Disabil       Date:  2018-07-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.